Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The weight-loss curve in STEP plateaus around 15% in most patients
See the science backed evidence for IV therapies here: maximmunity.ca/science.
Its triple-agonist activity and once-weekly schedule distinguish it from older incretin drugs, requiring carefully planned titration to balance efficacy and safety
Important safety information: Boxed warning: Semaglutide and tirzepatide have a boxed warning about thyroid C-cell tumors in rodents
While individual results vary based on personal health metrics, clinical data show that individuals using medical GLP-1 protocols lose an average of 15% to 20% of their total body weight when paired with positive lifestyle changes
US$ 26.17
US$ 27.52
US$ 27.82
US$ 29.75
US$ 20.06
US$ 27.33
